Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
RFK Jr.'s diet guidelines emphasize red meat, full-fat dairy. How healthy are they? - 2IAF intercepts over 90% of drones launched by Iran, Hezbollah during Operation Roaring Lion
- 3Israel approves death penalty law for Palestinians convicted of attacks
- 4Creative Do-It-Yourself Ventures for Each Expertise Level
- 5Scientists dove hundreds of feet into the ocean and found creatures no human has ever seen. Our trash beat us there
- Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up
- Russian military plane crashes in annexed Crimea, killing 29 people on board
- Parents speak out as 4-year-old fights button battery injury in intensive care unit
- Select Your Cherished Fish
- Experience Is standing by: 10 Pleasant Setting up camp Areas to
- Transcript: NASA's Jared Isaacman on "Face the Nation with Margaret Brennan," April 5, 2026
- Genome study reveals milestone in history of cat domestication
- 5 Great Youngster Care Administrations To Watch in 2024
- CDC vaccine panel votes to remove universal hepatitis B birth dose recommendation
